Free Trial

Northwest & Ethical Investments L.P. Purchases 11,125 Shares of Relx Plc $RELX

Relx logo with Computer and Technology background

Key Points

  • Northwest & Ethical Investments L.P. increased its stake in Relx Plc by 5.3% in the first quarter, owning 221,725 shares valued at approximately $11.18 million.
  • Relx recently declared a semi-annual dividend of $0.2634, with a dividend yield of 170.0% and a payout ratio of 28.49%.
  • Analysts have upgraded Relx from a "hold" rating to a "buy" rating, with five analysts recommending a buy and one giving a strong buy rating.
  • Looking to export and analyze Relx data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Northwest & Ethical Investments L.P. boosted its holdings in Relx Plc (NYSE:RELX - Free Report) by 5.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 221,725 shares of the technology company's stock after acquiring an additional 11,125 shares during the quarter. Northwest & Ethical Investments L.P.'s holdings in Relx were worth $11,177,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in RELX. Ameriprise Financial Inc. grew its position in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock worth $127,437,000 after purchasing an additional 2,208,119 shares during the period. Northern Trust Corp increased its position in Relx by 51.6% during the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after acquiring an additional 745,532 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Relx by 6,125.5% in the first quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company's stock valued at $34,232,000 after acquiring an additional 668,165 shares during the period. Carnegie Investment Counsel purchased a new position in Relx in the first quarter worth about $16,026,000. Finally, Bank of America Corp DE grew its stake in shares of Relx by 4.2% during the 4th quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock valued at $283,714,000 after purchasing an additional 253,107 shares during the period. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised Relx from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Buy".

Read Our Latest Report on Relx

Relx Price Performance

RELX traded down $0.5260 on Thursday, hitting $48.1640. 1,029,271 shares of the company's stock traded hands, compared to its average volume of 869,262. The company's 50 day simple moving average is $51.88 and its 200-day simple moving average is $51.51. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx Plc has a one year low of $44.19 and a one year high of $56.33. The firm has a market cap of $88.35 billion, a price-to-earnings ratio of 25.89, a P/E/G ratio of 3.12 and a beta of 0.88.

Relx Cuts Dividend

The business also recently announced a semi-annual dividend, which will be paid on Tuesday, September 16th. Investors of record on Friday, August 8th will be given a dividend of $0.2634 per share. The ex-dividend date is Friday, August 8th. This represents a dividend yield of 170.0%. Relx's dividend payout ratio is currently 28.49%.

Relx Company Profile

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Featured Articles

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines